ストックスクリーナーアプリを入手
52.49
0.40%
-0.21
アフターアワーズ：
52.86
0.37
+0.70%
前日終値:
$52.70
開ける：
$52.22
24時間の取引高:
31,746
Relative Volume:
0.31
時価総額：
$229.97M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-3.35%
1か月 パフォーマンス:
-9.55%
6か月 パフォーマンス:
+12.74%
1年 パフォーマンス:
+18.51%
1日の値動き範囲:
$51.50
$52.52
1週間の範囲:
$51.50
$54.09
52週間の値動き範囲:
$35.22
$58.84
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Company Profile
Compare XPH vs VTI, SPY, IVV, VB, QQQ
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
XPH
State Street Spdr S P Pharmaceuticals Etf
|
52.49 | 229.97M | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
323.18 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
State Street Spdr S P 500 Etf Trust
|
653.18 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
656.23 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
263.51 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
583.98 | 124.43B | 0 | 0 | 0 | 0.00 |
State Street Spdr S P Pharmaceuticals Etf (XPH) 最新ニュース
Stock List: Research Stocks from Around the World - GuruFocus
Prestige Bets $1 Billion On World's Most Iconic Nasal Strip - Benzinga
Prestige Bets $1 Billion On World's Most Iconic Nasal Strip - Benzinga
Beyond Tech Industry: Here's how Biotech ETFs Are Riding the AI Wave - TradingView
Biotech ETF With A Twist: Defiance To Donate Initial Advisory Profits To Autism Causes - Benzinga
These 5 Undervalued ETFs Could Be Bargains Right Now - AOL.com
South Korea's $350B U.S. Investment Pledge: ETFs That Could Gain - TradingView
BridgeBio Pharma Eyes First Treatment For Rare Muscle Disorder As Trial Data Shows Early Progress - Benzinga
Better S&P 500 ETF: State Street's SPY vs. Vanguard's VOO - The Motley Fool
Most and least shorted healthcare stocks with up to $2B market cap in February - Seeking Alpha
Best S&P 500 ETFs to Buy in 2026 - The Motley Fool
How to Invest in SPDR S&P Biotech ETF (XBI) - The Motley Fool
Stock Market Today: Dow Jones, S&P500, Nasdaq Futures Decline After SC Strikes Down Trump's Emergency Tariffs— NVO, MSTR, VNDA In Focus (UPDATED) - Benzinga
XPH’s 29% Run Looks Tempting, But The 5y Chart Is A Warning - AOL.com
State Street SPDR S&P Global Dividend ETF Holdings - Quiver Quantitative
Best Blue Chip ETFs to Buy in 2026 - The Motley Fool
FDA Commissioner Raises Concerns About US Pharma Lagging Behind China In Drug Development - Stocktwits
PTC Therapeutics Faces Translarna Setback While Valuation Signals Potential Upside - simplywall.st
A Golden Age of Biotech Is Upon Us, Thanks to AI. This ETF Offers 40% Upside. - Barron's
Why Vertex Pharmaceuticals (VRTX) Is Up 6.0% After Profit Rebound And Non-CF Pipeline UpdateAnd What's Next - simplywall.st
NATCO Pharma Limited Just Missed Revenue By 8.4%: Here's What Analysts Think Will Happen Next - simplywall.st
Most and least shorted healthcare stocks with up to $2B market cap - Seeking Alpha
Rohto Pharmaceutical Co.,Ltd. Just Beat EPS By 6.6%: Here's What Analysts Think Will Happen Next - simplywall.st
XLP vs. FTXG: The Clash of Consumer Staple ETFs - AOL.com
Zealand Pharma A/S (CPH:ZEAL) most popular amongst retail investors who own 46% of the shares, institutions hold 38% - simplywall.st
Arrowhead Pharmaceuticals (ARWR) Valuation Check After Earnings Jump And S&P Index Move - simplywall.st
SPDR's Aerospace & Defense ETF Took An Unusual Approach That Smoked The S&P 500 With 54% Run - 24/7 Wall St.
XPH Should I Buy - Intellectia AI
The top performing pharma and biotech stocks as group sees resurgence (PJP:NYSEARCA) - Seeking Alpha
Most and least shorted mid-to mega-cap healthcare stocks in January - Seeking Alpha
Should State Street SPDR S&P 600 Small Cap Growth ETF (SLYG) Be on Your Investing Radar? - Yahoo Finance
Analysts Expect Breakeven For Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Before Long - simplywall.st
Sector Alert: 4 Healthcare ETFs Poised for Explosive Growth Now - The Motley Fool
Arrowhead Joins S&P 400 As Profitability Shifts Investor Focus - simplywall.st
Should You Invest in the State Street SPDR S&P Regional Banking ETF (KRE)? - Yahoo Finance
Is State Street SPDR S&P Regional Banking ETF (KRE) a Strong ETF Right Now? - Yahoo Finance
XLP Delivers Pure-Play Staples While IYK Adds Healthcare. Which Strategy Wins? - AOL.com
Is State Street SPDR S&P Capital Markets ETF (KCE) a Strong ETF Right Now? - Yahoo Finance
Is State Street SPDR S&P Insurance ETF (KIE) a Strong ETF Right Now? - Yahoo Finance
The 10 Best Performing ETFs Over the Last 10 Years - YCharts
How Investors Are Reacting To ARS Pharmaceuticals (SPRY) Expanded EU Pediatric Nod For Needle-Free Anaphylaxis Treatment - simplywall.st
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a strong ETF right now? - MSN
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now? - sharewise.com
Pharma stocks are close to ‘breaking out.’ Earnings could set them free. - MSN
Pharma Stocks Are Close to Breaking Out. Earnings Could Set Them Free. - Barron's
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)? - sharewise.com
Invesco’s PXH ETF Jumped 38% as Emerging Markets Finally Heat Up - AOL.com
BBH: Mature Biotech Exposure, But Limited Growth Ahead (NASDAQ:BBH) - Seeking Alpha
5 Biggest Pharmaceutical ETFs for Investors in 2026 - Nasdaq
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Winners & Losers: The ETF Playbook to Glide Trump's Great Healthcare Plan - sharewise.com
State Street Spdr S P Pharmaceuticals Etf (XPH) 財務データ
State Street Spdr S P Pharmaceuticals Etf (XPH) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.55%
1.16%
大文字化:
|
ボリューム (24 時間):